MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by lalala1on Nov 30, 2007 2:09pm

114 Views

Post# 13896757

RE: ask yourself

From my conversations with IR I also believe that one of MIR's major hurdles is to find the Human Capital needed to sell, market, and to some extent produce their product. I think the recent attention has caught them off guard, and that they were expecting slowly increasing attention over time. I say this mainly because these are the areas I surmised from my conversation with Dr. Smith. Also one person asked the production capabilities of MIR, it’s 250,000 a month normally but they can push it to 500,000 if they need to (but I don’t believe for long).

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments